PIP5KL1

gene
On this page

Also known as bA203J24.5MGC46424PIPKH

Summary

PIP5KL1 (phosphatidylinositol-4-phosphate 5-kinase like 1, HGNC:28711) is a protein-coding gene on chromosome 9q34.11, encoding Phosphatidylinositol 4-phosphate 5-kinase-like protein 1 (Q5T9C9). May act as a scaffold to localize and regulate type I PI(4)P 5-kinases to specific compartments within the cell, where they generate PI(4,5)P2 for actin nucleation, signaling and scaffold protein recruitment and conversion to PI(3,4,5)P3.

PIP5KL1 is a phosphoinositide kinase-like protein that lacks intrinsic lipid kinase activity but associates with type I PIPKs (see PIP5K1A; MIM 603275) and may play a role in localization of PIPK activity (Chang et al., 2004 [PubMed 14701839]).

Source: NCBI Gene 138429 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 64 total
  • MANE Select transcript: NM_001135219

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28711
Approved symbolPIP5KL1
Namephosphatidylinositol-4-phosphate 5-kinase like 1
Location9q34.11
Locus typegene with protein product
StatusApproved
AliasesbA203J24.5, MGC46424, PIPKH
Ensembl geneENSG00000167103
Ensembl biotypeprotein_coding
OMIM612865
Entrez138429

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 10 protein_coding_CDS_not_defined, 2 protein_coding

ENST00000300432, ENST00000388747, ENST00000464108, ENST00000464759, ENST00000476624, ENST00000477191, ENST00000485562, ENST00000490773, ENST00000492296, ENST00000495448, ENST00000497234, ENST00000498783

RefSeq mRNA: 2 — MANE Select: NM_001135219 NM_001135219, NM_173492

CCDS: CCDS48030, CCDS6885

Canonical transcript exons

ENST00000388747 — 10 exons

ExonStartEnd
ENSE00001843550127920881127922114
ENSE00002288474127930723127930777
ENSE00003520527127927153127927208
ENSE00003529788127929688127929885
ENSE00003546523127928065127928219
ENSE00003568140127925867127925979
ENSE00003644117127928433127928483
ENSE00003645938127925107127925260
ENSE00003670317127927297127927331
ENSE00003692337127927648127927772

Expression profiles

Bgee: expression breadth ubiquitous, 158 present calls, max score 83.72.

FANTOM5 (CAGE): breadth broad, TPM avg 0.5574 / max 136.5879, expressed in 232 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
1026210.159055
1026230.154372
1026200.128039
1026180.081547
1026220.02528
1026190.00932

Top tissues by expression

249 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
upper arm skinUBERON:000426383.72gold quality
lower esophagus mucosaUBERON:003583481.46gold quality
bone marrow cellCL:000209277.69gold quality
left ventricle myocardiumUBERON:000656676.69gold quality
cardiac muscle of right atriumUBERON:000337976.68gold quality
parotid glandUBERON:000183175.28gold quality
olfactory segment of nasal mucosaUBERON:000538673.88gold quality
skin of abdomenUBERON:000141673.80gold quality
stromal cell of endometriumCL:000225573.24gold quality
esophagus mucosaUBERON:000246972.97gold quality
cortical plateUBERON:000534372.69gold quality
prefrontal cortexUBERON:000045172.43gold quality
skin of legUBERON:000151172.32gold quality
ventricular zoneUBERON:000305372.26gold quality
pituitary glandUBERON:000000771.70gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099171.54gold quality
adenohypophysisUBERON:000219671.09gold quality
epithelial cell of pancreasCL:000008370.81gold quality
zone of skinUBERON:000001470.73gold quality
ectocervixUBERON:001224970.58gold quality
saliva-secreting glandUBERON:000104470.36gold quality
minor salivary glandUBERON:000183070.06gold quality
mucosa of stomachUBERON:000119969.85gold quality
vaginaUBERON:000099669.62gold quality
right frontal lobeUBERON:000281069.61gold quality
nasal cavity epitheliumUBERON:000538469.52gold quality
esophagusUBERON:000104369.09gold quality
right hemisphere of cerebellumUBERON:001489068.99gold quality
anterior cingulate cortexUBERON:000983568.91gold quality
kidney epitheliumUBERON:000481968.63gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-GEOD-36552no19.10
E-ANND-3no2.47

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

19 targeting PIP5KL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3605-5P99.9667.12932
HSA-MIR-971899.9468.91918
HSA-MIR-6753-3P99.9366.57637
HSA-MIR-7107-3P99.9366.73627
HSA-MIR-368699.9070.532432
HSA-MIR-137-3P99.8774.742401
HSA-MIR-452799.6667.43714
HSA-MIR-7157-5P99.6669.331829
HSA-MIR-6503-5P99.6266.96597
HSA-MIR-431099.5968.842527
HSA-MIR-1252-3P99.5567.712862
HSA-MIR-312399.4767.152693
HSA-MIR-431199.3170.473041
HSA-MIR-338-3P98.1467.381137
HSA-MIR-556-5P97.7566.17473
HSA-MIR-805597.6266.091023
HSA-MIR-61096.8467.98905
HSA-MIR-3679-5P94.7566.46862
HSA-MIR-1185-5P94.4765.95725

Literature-anchored findings (GeneRIF, showing 3)

  • PIPKH acts as a scaffold to localize and regulate type I PI(4)P 5-kinases and the synthesis of PI(3,4,5)P(3) (PMID:14701839)
  • These studies indicate a functional negative correlation between elevated levels of PIP5KL1 and the development of human gastric cancer. (PMID:19680787)
  • Enforced expression of phosphatidylinositol 4-phosphate 5-kinase homolog alters PtdIns(4,5)P2 distribution and the localization of small G-proteins. (PMID:31616009)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriopip5kl1ENSDARG00000060946
mus_musculusPip5kl1ENSMUSG00000046854
rattus_norvegicusPip5kl1ENSRNOG00000048676

Paralogs (6): PIP5K1B (ENSG00000107242), PIP5K1A (ENSG00000143398), PIP4K2A (ENSG00000150867), PIP4K2C (ENSG00000166908), PIP5K1C (ENSG00000186111), PIP4K2B (ENSG00000276293)

Protein

Protein identifiers

Phosphatidylinositol 4-phosphate 5-kinase-like protein 1Q5T9C9 (reviewed: Q5T9C9)

All UniProt accessions (1): Q5T9C9

UniProt curated annotations — full annotation on UniProt →

Function. May act as a scaffold to localize and regulate type I PI(4)P 5-kinases to specific compartments within the cell, where they generate PI(4,5)P2 for actin nucleation, signaling and scaffold protein recruitment and conversion to PI(3,4,5)P3.

Subunit / interactions. Heterodimerizes with other type I phosphatidylinositol 4-phosphate 5-kinase.

Subcellular location. Cytoplasm. Membrane.

Isoforms (2)

UniProt IDNamesCanonical?
Q5T9C9-11yes
Q5T9C9-22

RefSeq proteins (2): NP_001128691, NP_775763 (=MANE)

Domains & families (InterPro)

IDNameType
IPR002498PInositol-4-P-4/5-kinase_coreDomain
IPR023610PInositol-4/5-P-5/4-kinaseFamily
IPR027483PInositol-4-P-4/5-kinase_C_sfHomologous_superfamily
IPR027484PInositol-4-P-5-kinase_NHomologous_superfamily

Pfam: PF01504

Catalyzed reactions (Rhea), 1 shown:

  • a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate) + ATP = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + ADP + H(+) (RHEA:14425)

UniProt features (3 total): chain 1, domain 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5T9C9-F185.210.66

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 96 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GOBP_PHOSPHOLIPID_METABOLIC_PROCESS, GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS, GOBP_GLYCEROLIPID_METABOLIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION, GOBP_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION, GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS, GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_BIOSYNTHETIC_PROCESS, GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL

GO Biological Process (8): negative regulation of mitochondrial membrane potential (GO:0010917), negative regulation of cell migration (GO:0030336), positive regulation of apoptotic process (GO:0043065), phosphatidylinositol phosphate biosynthetic process (GO:0046854), negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051898), lipid metabolic process (GO:0006629), regulation of signal transduction (GO:0009966), phosphatidylinositol metabolic process (GO:0046488)

GO Molecular Function (6): ATP binding (GO:0005524), 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0016308), nucleotide binding (GO:0000166), kinase activity (GO:0016301), transferase activity (GO:0016740), phosphatidylinositol kinase activity (GO:0052742)

GO Cellular Component (5): cytosol (GO:0005829), plasma membrane (GO:0005886), cell projection (GO:0042995), cytoplasm (GO:0005737), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
negative regulation of membrane potential1
regulation of mitochondrial membrane potential1
cell migration1
regulation of cell migration1
negative regulation of cell motility1
apoptotic process1
regulation of apoptotic process1
positive regulation of programmed cell death1
glycerophospholipid biosynthetic process1
phosphatidylinositol 3-kinase/protein kinase B signal transduction1
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction1
negative regulation of intracellular signal transduction1
primary metabolic process1
signal transduction1
regulation of cell communication1
regulation of signaling1
regulation of response to stimulus1
phosphorus metabolic process1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
phosphatidylinositol kinase activity1
nucleoside phosphate binding1
heterocyclic compound binding1
transferase activity, transferring phosphorus-containing groups1
catalytic activity1
lipid kinase activity1
phosphotransferase activity, alcohol group as acceptor1
cytoplasm1
membrane1
cell periphery1
intracellular anatomical structure1

Protein interactions and networks

STRING

684 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PIP5KL1ANKRD13BQ86YJ7512
PIP5KL1PIP5K1AQ99755499
PIP5KL1TMEM25Q86YD3491
PIP5KL1TMEM91Q6ZNR0451
PIP5KL1USP17L7P0C7H9448
PIP5KL1TMEM117Q9H0C3441
PIP5KL1MBOAT1Q6ZNC8405
PIP5KL1GRIFINA4D1Z8403
PIP5KL1EEIG1Q5T9C2400
PIP5KL1DPM2O94777398
PIP5KL1PIK3CDO00329394
PIP5KL1PLPPR3Q6T4P5364
PIP5KL1GPR160Q9UJ42355
PIP5KL1USP53Q70EK8342
PIP5KL1EML1O00423338

IntAct

3 interactions, top by confidence:

ABTypeScore
PIP5KL1HSPA9psi-mi:“MI:0915”(physical association)0.400
PIP5KL1ABCF3psi-mi:“MI:0915”(physical association)0.400

BioGRID (5): PIP5K1B (Affinity Capture-Western), PIP5K1C (Affinity Capture-Western), PIP5K1A (Affinity Capture-Western), PIP5KL1 (Proximity Label-MS), ABCF3 (Affinity Capture-MS)

ESM2 similar proteins: A4FV98, A5PK51, A6NDG6, E1BE10, O00587, O35595, O95294, P60487, Q12788, Q17QS4, Q1JPJ0, Q2T9S4, Q2TBI8, Q32NY4, Q3T063, Q3ZBF9, Q501J2, Q5E9V4, Q5F4B1, Q5IS64, Q5SUV1, Q5T9C9, Q6AYG0, Q6AYR8, Q6XQN1, Q6XQN6, Q6ZMM2, Q80US4, Q8BNV1, Q8BZG5, Q8CC86, Q8IZ69, Q8N9H8, Q8NE01, Q8R2H9, Q8TCT1, Q8VCA8, Q8VD52, Q969S8, Q96AZ1

Diamond homologs: B0G126, Q17QS4, Q5T9C9, Q6U7H8, Q9LMN1, Q9SSJ8, Q9LUM0, O48709, O96838, P38994, Q56YP2, Q6EX42, Q8L796, Q8L850, Q8RY89, Q9M149, Q9M1K2, Q9SFB8, Q9SLG9, Q9SUI2, O13853, O88377, Q0WUR5, Q55GN6, Q80XI4, Q9XID0

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

64 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance53
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1799 predictions. Top by Δscore:

VariantEffectΔscore
9:127925101:GCTCA:Gdonor_loss1.0000
9:127925102:CTCAC:Cdonor_loss1.0000
9:127925103:TCACC:Tdonor_loss1.0000
9:127925104:CACCT:Cdonor_loss1.0000
9:127925105:ACCTG:Adonor_loss1.0000
9:127925106:C:CAdonor_loss1.0000
9:127925981:T:Aacceptor_loss1.0000
9:127927148:CTCA:Cdonor_loss1.0000
9:127927150:CA:Cdonor_loss1.0000
9:127927151:A:ACdonor_gain1.0000
9:127927152:C:CCdonor_gain1.0000
9:127927152:CCT:Cdonor_gain1.0000
9:127927206:CGT:Cacceptor_gain1.0000
9:127927329:CTC:Cacceptor_gain1.0000
9:127927644:GTACC:Gdonor_loss1.0000
9:127927646:A:ACdonor_gain1.0000
9:127927646:A:Tdonor_loss1.0000
9:127927646:AC:Adonor_gain1.0000
9:127927647:C:CAdonor_loss1.0000
9:127927647:C:CCdonor_gain1.0000
9:127927647:CC:Cdonor_gain1.0000
9:127927700:G:Cdonor_gain1.0000
9:127927768:CGTGG:Cacceptor_gain1.0000
9:127927769:GTGG:Gacceptor_gain1.0000
9:127927770:TGG:Tacceptor_gain1.0000
9:127927770:TGGC:Tacceptor_loss1.0000
9:127927771:GG:Gacceptor_gain1.0000
9:127927772:GCT:Gacceptor_loss1.0000
9:127927773:C:CCacceptor_gain1.0000
9:127927773:C:CGacceptor_loss1.0000

AlphaMissense

2533 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:127925968:T:AK221I0.997
9:127925967:T:AK221N0.994
9:127925967:T:GK221N0.994
9:127927748:C:AK153N0.985
9:127927748:C:GK153N0.985
9:127925892:G:CN246K0.984
9:127925892:G:TN246K0.984
9:127925901:C:AK243N0.982
9:127925901:C:GK243N0.982
9:127925181:G:CS281R0.980
9:127925181:G:TS281R0.980
9:127925183:T:GS281R0.980
9:127925899:T:GD244A0.976
9:127925969:T:CK221E0.976
9:127925973:G:CD219E0.976
9:127925973:G:TD219E0.976
9:127925900:C:GD244H0.974
9:127928214:G:CF95L0.974
9:127928214:G:TF95L0.974
9:127928216:A:GF95L0.974
9:127925974:T:CD219G0.973
9:127925974:T:GD219A0.972
9:127925978:A:CY218D0.972
9:127928174:G:TR109S0.972
9:127928103:G:CF132L0.971
9:127928103:G:TF132L0.971
9:127928105:A:GF132L0.971
9:127927185:G:CS206R0.970
9:127927185:G:TS206R0.970
9:127927187:T:GS206R0.970

dbSNP variants (sampled 300 via entrez): RS1000048528 (9:127923478 C>G), RS1000268301 (9:127923661 CCAA>C), RS1000997704 (9:127930149 G>A), RS1001032846 (9:127923707 G>A,C), RS1001035524 (9:127921812 A>T), RS1001124699 (9:127927703 G>A,C), RS1001836891 (9:127932609 C>G), RS1001899461 (9:127932190 A>C), RS1002057554 (9:127920554 C>T), RS1002381954 (9:127929379 C>G), RS1002432772 (9:127929753 T>A), RS1003116633 (9:127926667 C>T), RS1003249198 (9:127930941 G>A,C), RS1003362980 (9:127921243 G>A), RS1003387196 (9:127927932 A>G)

Disease associations

OMIM: gene MIM:612865 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST005951_65Body mass index5.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004340body mass index

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Idecreases expression1
bisphenol Adecreases expression1
sodium arseniteincreases abundance, affects cotreatment, decreases expression1
perfluorooctanoic acidincreases expression1
2-amino-3,8-dimethylimidazo(4,5-f)quinoxalinedecreases expression1
clothianidindecreases expression1
bisphenol Sincreases methylation1
jinfukangaffects cotreatment, increases expression1
Microplasticsdecreases expression, increases abundance1
Arsenicaffects cotreatment, decreases expression, increases abundance1
Cisplatinaffects cotreatment, increases expression1
Polyethylene Terephthalatesdecreases expression, increases abundance1
Rotenoneincreases expression1
Smokedecreases expression1
Valproic Acidincreases methylation1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.